Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
CD4
CD40L
HIV
MDSC
NHP
SIV
macaques
vaccine
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
28 02 2020
28 02 2020
Historique:
received:
15
11
2019
accepted:
05
12
2019
pubmed:
4
1
2020
medline:
4
9
2020
entrez:
4
1
2020
Statut:
epublish
Résumé
Immunization with recombinant ALVAC/gp120 alum vaccine provided modest protection from human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) acquisition in humans and macaques. Vaccine-mediated protection was associated with the elicitation of IgG against the envelope V2 loop and of envelope-specific CD4
Identifiants
pubmed: 31896599
pii: JVI.01933-19
doi: 10.1128/JVI.01933-19
pmc: PMC7158742
pii:
doi:
Substances chimiques
AIDS Vaccines
0
ALVAC vaccine
0
HIV Envelope Protein gp120
0
Viral Vaccines
0
gp120 protein, Human immunodeficiency virus 1
0
CD40 Ligand
147205-72-9
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : THA-11906
Pays : Canada
Références
J Immunol. 2005 Sep 15;175(6):3502-7
pubmed: 16148092
PLoS One. 2014 Feb 04;9(2):e87572
pubmed: 24504509
Nat Med. 2016 Jul;22(7):762-70
pubmed: 27239761
J Virol. 2013 Sep;87(18):10163-72
pubmed: 23843636
Sci Transl Med. 2014 Mar 19;6(228):228ra39
pubmed: 24648342
Int Arch Allergy Immunol. 1997 Aug;113(4):393-9
pubmed: 9250584
J Immunol. 2018 Jan 1;200(1):286-294
pubmed: 29180488
Immunity. 1994 Jun;1(3):167-78
pubmed: 7534202
Clin Exp Immunol. 2014 Oct;178(1):102-11
pubmed: 24924152
J Virol. 2014 Sep 1;88(17):9579-89
pubmed: 24920805
Curr Protoc Immunol. 2005 Jan;Chapter 12:Unit 12.11
pubmed: 18432938
Immunol Invest. 1997 Jan-Feb;26(1-2):15-28
pubmed: 9037609
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51
pubmed: 1380261
AIDS Res Hum Retroviruses. 2012 Nov;28(11):1444-57
pubmed: 23035746
Cancer Immunol Immunother. 2012 Feb;61(2):255-263
pubmed: 22120756
J Virol. 2015 Apr;89(8):4690-5
pubmed: 25653428
J Virol. 2013 Mar;87(6):3538-48
pubmed: 23325681
Nature. 1998 Jun 4;393(6684):478-80
pubmed: 9624004
Front Immunol. 2019 May 14;10:1072
pubmed: 31139193
Front Immunol. 2018 Feb 26;9:348
pubmed: 29535724
J Immunol. 2015 Oct 1;195(7):3227-36
pubmed: 26297759
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Annu Rev Med. 2015;66:423-37
pubmed: 25341006
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):393-400
pubmed: 21239998
Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S80-4
pubmed: 25151483
J Virol. 2002 Jan;76(1):292-302
pubmed: 11739694
Nat Biotechnol. 2015 Jun;33(6):610-6
pubmed: 26006008
J Infect Dis. 2012 Aug 1;206(3):431-41
pubmed: 22634875
Cytometry A. 2012 May;81(5):360-1
pubmed: 22438313
Virology. 1990 Nov;179(1):247-66, 517-63
pubmed: 2219722
J Virol. 2006 Feb;80(4):1762-72
pubmed: 16439533
J Immunol. 2013 Mar 15;190(6):2495-9
pubmed: 23401588
Vaccine. 2010 Jul 12;28(31):5114-27
pubmed: 20471443
J Virol Methods. 2010 Feb;163(2):287-94
pubmed: 19878696
J Immunol. 2016 Oct 1;197(7):2726-37
pubmed: 27591322
AIDS. 1991 Jul;5(7):829-36
pubmed: 1716442
Lancet. 2015 Jul 11;386(9989):171-218
pubmed: 26117719
J Exp Med. 2009 May 11;206(5):1117-34
pubmed: 19414559
Vaccine. 1991 Mar;9(3):190-3
pubmed: 2042391
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):185-90
pubmed: 9874793
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
PLoS One. 2013 Sep 26;8(9):e75665
pubmed: 24086607
J Virol. 2015 Aug;89(16):8525-39
pubmed: 26041302
Oncoimmunology. 2013 Jan 1;2(1):e22546
pubmed: 23483661
Nat Med. 2018 Jun;24(6):847-856
pubmed: 29785023
Sci Transl Med. 2015 Jul 29;7(298):298ra120
pubmed: 26223303
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
J Virol. 2013 Feb;87(3):1708-19
pubmed: 23175374
J Virol. 2009 Feb;83(3):1216-27
pubmed: 19036823
AIDS. 2016 Jun 19;30(10):1521-1531
pubmed: 26959508
Clin Cancer Res. 2007 Feb 15;13(4):1083-8
pubmed: 17317815
J Exp Med. 1996 Aug 1;184(2):747-52
pubmed: 8760829
J Virol. 2013 Apr;87(8):4584-95
pubmed: 23408608
Virology. 1993 Aug;195(2):845-50
pubmed: 8337851
Immunol Lett. 2013 Jun;153(1-2):58-61
pubmed: 23892087
Hum Vaccin. 2010 Apr;6(4):355-9
pubmed: 20372075
Vaccine. 2008 Jul 29;26(32):4062-72
pubmed: 18562053
Circulation. 1999 Aug 10;100(6):614-20
pubmed: 10441098
Immunol Rev. 2009 May;229(1):152-72
pubmed: 19426221
J Virol. 2005 Aug;79(16):10108-25
pubmed: 16051804
J Immunol. 2012 May 15;188(10):5166-76
pubmed: 22529301
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):297-309
pubmed: 12787567
J Virol. 2014 Feb;88(3):1809-14
pubmed: 24257612
Vaccine. 2009 May 21;27(24):3165-74
pubmed: 19446187
J Exp Med. 2000 Feb 21;191(4):651-60
pubmed: 10684857
J Exp Med. 1968 Oct 1;128(4):801-20
pubmed: 5691985
Immunol Res. 2001;24(2):97-109
pubmed: 11594459
Lancet Infect Dis. 2012 Jul;12(7):531-7
pubmed: 22652344
Sci Transl Med. 2014 Mar 19;6(228):228ra38
pubmed: 24648341
J Clin Invest. 2002 Mar;109(5):613-20
pubmed: 11877469